...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis.
【24h】

Plasma ghrelin levels in children with chronic renal failure on peritoneal dialysis.

机译:腹膜透析患慢性肾衰竭的儿童血浆生长素释放肽水平。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: Malnutrition and loss of appetite represent a serious problem in children with chronic renal failure. Ghrelin is a newly described hormone involved in control of growth hormone secretion, stimulation of food intake, and regulation of energy balance. METHODS: Plasma ghrelin levels were compared between 12 children on automated peritoneal dialysis (APD) and 9 children on conservative treatment of chronic renal failure. Eight healthy children matched for age and body mass index (BMI) served as a control group. RESULTS: Plasma ghrelin levels were similar in children on APD (698.3 +/- 59.7 pg/mL) and children on conservative treatment (675.4 +/- 41.9 pg/mL) compared to healthy controls (700.1 +/- 24.7 pg/mL). There was no difference in plasma ghrelin levels in children with chronic renal failure regardless of the method of treatment (peritoneal dialysis vs conservative treatment). The plasma ghrelin index was similar in all three investigated groups: APD 40.2 +/- 8.7 vs conservative treatment 39.1 +/- 5.6 vs controls 41.0 +/- 7.8 (pg/mL)/BMI (kg/m2). Plasma ghrelin levels did not correlate with age, duration of dialysis treatment, height, weight, BMI, creatinine and urea levels, adequacy parameters, or nightly glucose load. CONCLUSION: Plasma ghrelin levels in children on APD were not different from levels in children on conservative treatment or healthy controls with comparable BMI. The persistent state of toxic influence of uremic end-products could be responsible for such a lack of correlation with anthropometrical parameters. Further studies on a larger group of children on APD are needed to clarify the effect of ghrelin on nutritional status in children with chronic renal failure.
机译:目的:营养不良和食欲不振是慢性肾功能衰竭儿童的严重问题。 Ghrelin是一种新近描述的激素,参与生长激素分泌的控制,食物摄入的刺激和能量平衡的调节。方法:比较了12例接受自动腹膜透析(APD)的儿童和9例接受慢性肾脏衰竭保守治疗的儿童的血浆生长素释放肽水平。八个年龄和体重指数(BMI)匹配的健康儿童作为对照组。结果:与健康对照组(700.1 +/- 24.7 pg / mL)相比,接受APD的儿童(698.3 +/- 59.7 pg / mL)和接受保守治疗的儿童(675.4 +/- 41.9 pg / mL)的血浆生长素释放肽水平相似。无论采用何种治疗方法(腹膜透析与保守治疗),患有慢性肾功能衰竭的儿童血浆生长激素释放肽水平均无差异。在所有三个研究组中,血浆生长素释放肽指数相似:APD 40.2 +/- 8.7 vs保守治疗39.1 +/- 5.6 vs对照41.0 +/- 7.8(pg / mL)/ BMI(kg / m2)。血浆生长素释放肽水平与年龄,透析治疗持续时间,身高,体重,BMI,肌酐和尿素水平,充足性参数或夜间葡萄糖负荷无关。结论:APD患儿血浆ghrelin水平与保守治疗或健康对照者BMI相当。尿毒症终产物毒性影响的持续状态可能是与人体测量学参数缺乏相关性的原因。需要进一步研究更多儿童的APD,以阐明生长激素释放肽对慢性肾功能衰竭儿童营养状况的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号